![Michael Berg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Berg
Teknisk/Vetenskaplig/F&U Direktör på
TEARLAB CORPORATION
Profil
Michael Berg is currently the Head-Regulatory, Reimbursement & Clinical at TearLab Corporation, Inc. and the President at Hemocue, Inc. He completed his undergraduate degree at the University of Notre Dame.
Aktiva positioner av Michael Berg
| Företag | Position | Start |
|---|---|---|
| TEARLAB CORPORATION | Teknisk/Vetenskaplig/F&U Direktör | - |
Hemocue, Inc.
 Hemocue, Inc. Medical SpecialtiesHealth Technology Part of Quest Diagnostics, Inc., Hemocue, Inc. is a provider of point-of-care diagnostic solutions specializing in hematology and diabetes management. The company is based in Cypress, CA. The company offers portable testing systems, including the Hemocue® Hb 201, Hb 301, Hb 801, plasma/low Hb, WBC, WBC diff, Glucose 201+, and HbA1c 501 systems, which deliver rapid results to support clinical decisions in settings such as primary care, hospitals, blood banks, public health, and remote locations. The company's devices use microcuvette technology, are factory calibrated, require small blood samples, and feature quality controls, barcode scanning, and connectivity options. Hemocue also supplies safety lancets, cleaning materials, control solutions, thermal printers, and docking stations to optimize device performance. The company provides educational resources and customer support for healthcare professionals. | President | 2010-05-20 |
Michael Bergs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
47
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
TearLab Corp., Inc.
 TearLab Corp., Inc. Medical SpecialtiesHealth Technology Develops point-of-care portable devices for measuring osmolarity to treat eye disorders | Health Technology |
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hemocue, Inc.
Hemocue, Inc. Medical SpecialtiesHealth Technology Part of Quest Diagnostics, Inc., Hemocue, Inc. is a provider of point-of-care diagnostic solutions specializing in hematology and diabetes management. The company is based in Cypress, CA. The company offers portable testing systems, including the Hemocue® Hb 201, Hb 301, Hb 801, plasma/low Hb, WBC, WBC diff, Glucose 201+, and HbA1c 501 systems, which deliver rapid results to support clinical decisions in settings such as primary care, hospitals, blood banks, public health, and remote locations. The company's devices use microcuvette technology, are factory calibrated, require small blood samples, and feature quality controls, barcode scanning, and connectivity options. Hemocue also supplies safety lancets, cleaning materials, control solutions, thermal printers, and docking stations to optimize device performance. The company provides educational resources and customer support for healthcare professionals. | Health Technology |
